How Modeling & Simulation is Addressing the Immunogenicity Challenge: An academic nicety is now a drug development and regulatory differentiator
Learn how modeling and simulation can help drug developers overcome the immunogenicity challenge, a major…
Certara2023 年 1 月 30 日
《通货膨胀削减法》会影响药物开发决策吗？
The short answer is yes. In fact, passage of the Inflation Reduction Act (H.R. 5376)…
Certara2023 年 1 月 27 日
How Drug Developers can Navigate the Inflation Reduction Act of 2022
Learn how the IRA will impact how new drugs are marketed and why negotiating pricing…
Certara2023 年 1 月 27 日
Exceling at Accelerating in Rare Disease Drug Development
By: Rajesh Krishna, PhD, FAAPS and Steve Sibley According to the National Institutes of Health,…
Certara2023 年 1 月 26 日
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma
An novel single dose regimen of tremelimumab combined with durvalumab could be a way to…
Certara2023 年 1 月 26 日
Tips & tricks for streamlining non-compartmental pharmacokinetic analysis
These Phoenix tips and tricks will help you exclude Lambda Z, name partial areas, and…
Certara2023 年 1 月 20 日
D360 as your organization’s extendable and central data engine
D360 is an industry-leading scientific data informatics platform providing a flexible, scalable, and customizable enterprise…
Certara2023 年 1 月 20 日
